About
Sancilio & Company develops, manufactures, and distributes biopharmaceutical products in the United States and internationally. Its cardiovascular health products include OCEAN BLUE PROFESSIONAL OMEGA-3 2100, which is made from fish oils to decrease the risk of arrhythmias. The company also provides dental health products, including LUDENT SODIUM FLUORIDE CHEWABLE TABLETS that provide fluoride to the children; MVC MULTIVITAMIN WITH FLUORIDE CHEWABLE TABLETS, which contain vitamins and minerals; and sodium fluoride drops. In addition, it offers women’s health products, which include Mylk, a multivitamin/mineral/essential fatty acid softgel; and Caltranate, a blend of calcium formulated to control the release of calcium. Further, Sancilio & Company provides pharmaceutical services, such as analytical chemistry, dissolution testing, formulation development, de-formulation studies, HPLC, GC, GC/MS, and LC/MS support, raw material sourcing, contract tablet, capsule, and soft gel production,
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 10 investors are based in Stuart, Florida, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Stuart, US
Contact Information
Find more investors like Sancilio
Search Investors